The Respokare N95 Mask is a medical-grade mask designed to provide wearers with a higher level

The Respokare N95 Mask is a medical-grade mask designed to provide wearers with a higher level of protection against harmful pathogens, including 18 different types of flu viruses and surrogates for SARS, MERS, and other pathogens. The mask is created by Innonix Technologies Limited, a biotechnology innovation powerhouse that develops disruptive technologies and products to address unmet health needs in medical, consumer, industrial, and government/military markets around the world.

The Respokare N95 mask features a proprietary active layer called TAM, which is used to allow people to breathe better and live healthier. The most influential product in the Respokare range is the RK-200-3013AN Anti-Viral Surgical N95 Mask, which is the first FDA-cleared anti-viral N95 facemask based on inactivation of influenza viruses. This mask also has an added antimicrobial and/or antiviral agent that kills specified pathogens under specified contact conditions.

The Respokare N95 mask has passed strict NIOSH certification and is 510K cleared. This means that it has been tested for effectiveness against a variety of harmful pathogens and has been shown to be effective in reducing wearer exposure to these pathogens. The Respokare brand is trustworthy and is known for producing high-quality medical-grade masks that are effective in protecting wearers from harmful pathogens.

In conclusion, the Respokare N95 Mask is a reliable and effective medical-grade mask that can help protect wearers from harmful pathogens. It is created by a biotechnology innovation powerhouse that is committed to developing disruptive technologies and products to address unmet health needs. The RK-200-3013AN Anti-Viral Surgical N95 Mask is the most influential product in the Respokare range and has passed strict NIOSH certification and 510K clearance.

RespoKare

Typical product:rk 200 3040a 3041a

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.